CCEL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (19 Apr 2024 @ 15:57):

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use...

Stats
Today's Volume	22 984.00
Average Volume	10 684.00
Market Cap	60.78M
EPS	$0 ( 2024-04-19 )
Next earnings date	( $0.0400 ) 2024-07-12
Last Dividend	$0.900 ( 2022-09-01 )
Next Dividend	$0 ( N/A )
P/E	-6.47
ATR14	$0.171 (2.28%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-22	Portnoy Mark L.	Buy	25 000	Stock Option
2023-12-22	Mikulinsky Oleg	Buy	10 000	Stock Option
2023-12-22	Taymans Jill M	Buy	10 000	Stock Option
2023-12-22	Portnoy David	Buy	50 000	Stock Option
2023-10-10	Berger Harold D.	Buy	5 300	Stock Option

INSIDER POWER
81.81
Last 100 transactions
Buy: 2 158 485 \| Sell: 773 682

Volume Correlation

Long: 0.09 (neutral)

Short: -0.54 (weak negative)

Signal:(48.815) Neutral

Cryo-Cell International, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Cryo-Cell International, Correlation - Currency/Commodity

0.75
( moderate )

0.83
( strong )

0.00
( neutral )

0.89
( strong )

-0.35
( neutral )

-0.84
( strong negative )

Cryo-Cell International, Financials

Annual	2023
Revenue:	$31.34M
Gross Profit:	$22.90M (73.07 %)
EPS:	$-1.140

Q4	2023
Revenue:	$7.88M
Gross Profit:	$5.80M (73.65 %)
EPS:	$0

Q3	2023
Revenue:	$7.87M
Gross Profit:	$5.71M (72.60 %)
EPS:	$0.0800

Q2	2023
Revenue:	$7.77M
Gross Profit:	$5.63M (72.43 %)
EPS:	$0.0300

Financial Reports:

No articles found.

Cryo-Cell International, Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.900 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Cryo-Cell International, Dividend Information - No Dividend Player

Dividend Sustainability Score: 1.055 - low (50.00%) | Divividend Growth Potential Score: 2.98 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.900	2022-09-01
Last Dividend	$0.900	2022-09-01
Next Dividend	$0	N/A
Payout Date	2022-09-09
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.900	--
Avg. Dividend % Per Year	0.00%	--
Score	0.61	--
Div. Sustainability Score	1.055
Div.Growth Potential Score	2.98
Div. Directional Score	2.02	--

Next Divdend (Est)
(2024-04-20)

$0 Estimate 0.00 %

Dividend Stability

0.04 Very Bad

Dividend Score

0.61

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for PNK

Symbol	Title	Last dividend	Frequency	Yearly Dividend
PKKW	Ex Dividend Junior	2023-09-07	Semi-Annually	0.00%
HRNNF	Ex Dividend Knight	2023-09-12	Quarterly	0.00%
FMBM	Ex Dividend Knight	2023-08-11	Quarterly	0.00%
CPTP	Ex Dividend Knight	2023-08-10	Quarterly	0.00%
TNCAF	Ex Dividend Knight	2023-08-30	Quarterly	0.00%
RSKIA	Ex Dividend Knight	2023-09-28	Annually	0.00%
NUVR	Ex Dividend Junior	2023-06-02	Quarterly	0.00%
FULO	Ex Dividend Knight	2023-08-30	Quarterly	0.00%
EMYB	Ex Dividend Knight	2023-06-29	Annually	0.00%
WCRS	Ex Dividend Junior	2023-08-21	Quarterly	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.304	1.500	-6.08	-9.11	[0 - 0.5]
returnOnAssetsTTM	-0.156	1.200	-5.18	-6.22	[0 - 0.3]
returnOnEquityTTM	3.02	1.500	10.00	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.453	0.800	-2.73	-2.19	[1 - 3]
quickRatioTTM	0.362	0.800	-2.58	-2.06	[0.8 - 2.5]
cashRatioTTM	0.0195	1.500	-1.003	-1.504	[0.2 - 2]
debtRatioTTM	0.178	-1.500	7.03	-10.00	[0 - 0.6]
interestCoverageTTM	-9.95	1.000	-4.80	-4.80	[3 - 30]
operatingCashFlowPerShareTTM	1.067	2.00	9.64	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.153	2.00	9.92	10.00	[0 - 20]
debtEquityRatioTTM	-0.988	-1.500	-3.95	5.93	[0 - 2.5]
grossProfitMarginTTM	0.731	1.000	1.156	1.156	[0.2 - 0.8]
operatingProfitMarginTTM	-0.393	1.000	-9.85	-9.85	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.819	1.000	6.56	6.56	[0.2 - 2]
assetTurnoverTTM	0.512	0.800	9.92	7.94	[0.5 - 2]
Total Score				1.055

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-6.55	1.000	-0.763	0	[1 - 100]
returnOnEquityTTM	3.02	2.50	10.00	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.153	2.00	9.95	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.067	2.00	9.64	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.0147	1.500	-3.24	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.285	1.000	5.39	0	[0.1 - 0.5]
Total Score				2.98

Cryo-Cell International,

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.